A Phase 4, multicentre, randomized, single-blind clinical trial to evaluate the immunogenicity of the live, attenuated, oral rotavirus vaccine (116E), ROTAVAC®, administered simultaneously with or without the buffering agent in healthy infants in India

Background: The World Health Organization recommends that rotavirus vaccines should be included in all national immunization programs. Some currently licensed oral rotavirus vaccines contain a buffering agent (either as part of a ready-to-use liquid formulation or added during reconstitution) to red...

Descripción completa

Detalles Bibliográficos
Autores principales: Ella, Raches, Bobba, Radhika, Muralidhar, Sanjay, Babji, Sudhir, Vadrevu, Krishna Mohan, Bhan, Maharaj Kishan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6067888/
https://www.ncbi.nlm.nih.gov/pubmed/29543547
http://dx.doi.org/10.1080/21645515.2018.1450709

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6067888/
https://www.ncbi.nlm.nih.gov/pubmed/29543547
http://dx.doi.org/10.1080/21645515.2018.1450709

Ejemplares similares